Intra-amygdala infusion of 2-chloroadenosine suppresses amygdala- kindled seizures

Brain Research

Volumn 775, Issue 1-2, 1997, Pages 37-42

  Pourgholami, M H ^a   Rostampour, M ^b   Mirnajafi Zadeh, J ^b   Palizvan, M R ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

2 Chloroadenosine; Adenosine A1; Amygdala; Caffeine; Kindling; Receptor; Seizure

Indexed keywords

2 CHLOROADENOSINE; ADENOSINE A1 RECEPTOR; CAFFEINE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; INTRACEREBRAL DRUG ADMINISTRATION; KINDLING; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

2-CHLOROADENOSINE; AMYGDALA; ANIMALS; ANTICONVULSANTS; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; INJECTIONS; KINDLING, NEUROLOGIC; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; SEIZURES; TIME FACTORS;

EID: 0031460628     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00769-5     Document Type: Article

References (34)

1. Albertson T.E., Joy R.M., Stark L.G. Caffeine modification of kindled amygdaloid seizures. Pharmacol. Biochem. Behav. 19:1983;339-343.
2. Albertson T.E., Stark L.G., Joy R.M., Bowyer J.F. Aminophilline and kindled seizures. Exp. Neurol. 81:1983;703-713.
3. Bortolotto Z.A., Mello L.E., Turski L., Cavalheiro E.A. Effect of 2-chloroadenosine on amygdaloid and hippocampal kindled seizures. Arch. Int. Pharmacodyn. Ther. 277:1985;313-320.
4. Braas K.M., Newby A.C., Wilson V.S., Snyder S.H. Adenosine-containing neurons in the brain localized by immunocytochemistry. J. Neurosci. 6:1986;1952-1961.
5. Cain D.P. Bidirectional transfer of electrical and carbachol kindling. Brain Res. 260:1983;135-138.
6. Cain D.P., Desborough K.A., McKitrick D.J. Retardation of amygdala kindling by antagonism of NMD-aspartate and muscarinic cholinergic receptors: evidence for the summation of excitatory mechanisms in kindling. Exp. Neurol. 100:1988;179-187.
7. D.P. Cain, Kindling and the amygdala, in: D.P. Cain (Ed.), The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction, Wiley-Liss Inc., New York, 1992, pp. 539-560.
8. Cavalheiro E.A., Calderazzo L.S., Bortolotto Z.A., Mello L., Turski L. Anticonvulsant role of adenosine. Pol. J. Pharmacol. Pharm. 39:1987;537-543.
9. Chin J.H. Adenosine receptors in brain: neuromodulation and role in epilepsy. Ann. Neurol. 26:1989;695-698.
10. Corradetti R., Conte G.L., Moroni F., Passiani M.B., Pepeu G. Adenosine decreased aspartate and glutamate release from rat hippocampal slices. Eur. J. Pharmacol. 104:1984;19-26.
11. Croucher M.J., Bradford H.F. NMDA receptor blockade inhibits glutamate induced kindling of the rat amygdala. Brain Res. 506:1990;349-352.
12. Davis M., Rainnie D., Cassell M. Neurotransmission in the amygdala related to fear and anxiety. Trend Neurosci. 17:1994;204-214.
13. de Mendoça A., Riebeiro J.A. Adenosine inhibits the NMDA receptor mediated excitatory post-synaptic potential in the hippocampus. Brain Res. 606:1993;351-356.
14. De Sarro G., De Sarro A., Meldrum B.S. Anticonvulsant action of 2-chloroadenosine injected focally into the inferior colliculus and substantia nigra. Eur. J. Pharmacol. 194:1991;145-152.
15. Dragunow M., Goddard G.V. Adenosine modulation of amygdala kindling. Exp. Neurol. 84:1984;654-665.
16. Dragunow M., Goddard G.V., Laverty R. Is adenosine an endogenous anticonvulsant? Epilepsia. 26:1985;480-487.
17. Dragunow M. Adenosine: the brain's natural anticonvulsant. Trends Pharmacol. Sci. 7:1986;128-130.
18. Dragunow M. Purinergic mechanisms in epilepsy. Prog. Neurobiol. 31:1988;85-108.
19. Engelbrecht A.H., Russell V.A., Mintz M., Lamm C.L., Kellaway L., Herbert L.J., Taljaard J.J.F. Kindled seizures do not affect adenosinergic inhibition of DA or ACh release in rat accumbens or PFC. Pharmacol. Biochem. Behav. 55:1996;315-321.
20. Holmes K.H., Bilkey D.K., Laverty K., Goddard G.V. The N-methyl-D-aspartate antagonists aminophosphonovalerate and carboxypiperazinephosphonate retard the development and expression of kindled seizures. Brain Res. 506:1990;227-235.
21. Jacobson K.A., Van Golen P.J.M., William M. Adenosine receptors: pharmacology, structure activity relationships and therapeutic potential. Med. Chem. 35:1992;407-422.
22. Jacobson K.A., von Lubitz D.K.J.A., Daly J.W., Fredholm B.B. Adenosine receptor ligands: difference with acute versus chronic treatment. Trends Pharmacol. Sci. 17:1996;108-113.
23. 2-selective adenosine analogue CGS 21680 depresses locomotor activity but does not block amygdala kindled seizures in rats. Neurosci. Lett. 141:1992;247-250.
24. Lee K.S., Schubert P., Heinemann U. The anticonvulsant action of adenosine: a postsynaptic dendritic action by a possible endogenous anticonvulsant. Brain Res. 321:1984;160-164.
25. Pourgholami M.H., Fallahi M. The neuroleptic thioridazine exerts weak anticonvulsant activity in amygdala kindled rats. Pharmacol. Sci. 1:1995;577-580.
26. Pourgholami M.H., Mirnajafi-Zadeh J., Behzadi J. Intraperitoneal and intrahippocampal 2-chloroadenosine in amygdaloid kindled rats. Brain Res. 751:1997;259-264.
27. Racine R.J. Modification of seizure activity by electrical stimulation. 2. Motor seizure Electroencephalogr. Clin. Neurophysiol. 32:1972;281-294.
28. 2+ currents and synaptic transmission in cultured rat hippocampal pyramidal neurons. J. Physiol. 435:1991;373-393.
29. 1 receptors in the rat brain in the kindling model of epilepsy. Eur. J. Pharmacol. 265:1994;121-124.
30. Trussell L.O., Jackson M.B. Dependence of an adenosine-activated potassium current on a GTP binding protein in mammalian central neurons. J. Neurosci. 7:1987;3306-3316.
31. Wu L.G., Saggau P. Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of the hippocampus. Neuron. 12:1994;1139-1148.
32. Yokoyma N., Mori N., Kumashiro H. Chemical kindling induced by cAMP and transfer to electrical kindling. Brain Res. 492:1989;58-162.
33. Young D., Dragunow M. Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms. Neuroscience. 58:1994;245-261.
34. Zhang G., Franklin P.H., Murray T.F. Manipulation of endogenous adenosine in the rat prepirifirm cortex modulate seizure susceptibility. J. Pharmacol. Exp. Ther. 264:1993;1415-1424.